Renflexis

Merck & Co signs biosimilars deal for US veterans
Pharmaforum
Mon, 10/8/18 - 09:56 am
Merck
Veterans Affairs
Renflexis
inflammatory diseases
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Wed, 09/20/17 - 09:05 am
drug pricing
reimbursement
Remicade
biosimilars
Janssen
Inflectra
Pfizer
Renflexis
Merck
Merck undercuts Pfizer on Remicade biosimilar price
BioPharma Dive
Wed, 07/26/17 - 10:18 pm
Merck
Pfizer
Remicade
drug pricing
biosimilars
Renflexis
JNJ
Second biosimilar of Remicade approved in the US, but J&J not rattled
BioPharma Dive
Mon, 04/24/17 - 10:02 pm
Remicade
JNJ
biosimilars
Renflexis
Merck
Samsung Bioepis